Jennifer Dreyfus

MBA, M. Bioethics

Senior Consultant

With more than 25 years’ experience in healthcare, managed care and policy, Jennifer specializes in the interface between providers and payors, particularly in the areas of value-based purchasing, bundled payment and understanding financial risk. Over the course of her career, she has negotiated and managed provider-payor contracts for large group practices, community hospitals, academic medical centers and payors. Clients can rely on Jennifer’s subject matter expertise and support as they undertake risk contracts designed to offer high quality, coordinated care.

As CMS and other payors seek creative partnerships with oncology service providers, Jennifer guides clients in identifying ways to improve care, lower costs and succeed under episode-based payments. Her understanding of federal regulations and CMS financial incentives enables her to assist clients under the newly proposed CMS Oncology Care Model and other value-based purchasing arrangements. Jennifer also helps negotiate agreements with commercial insurers. Committed to care transformation, she works with providers to identify successful strategies for offering improved care at a lower cost. Jennifer designs reimbursement strategies that compensate providers for care transformation efforts.

With more than 20 years of consulting experience, Jennifer’s specialties include managed care, reimbursement, genomics, federal regulatory policy and strategic planning. Prior to becoming a consultant, she managed provider contracting for an almost 500,000 member independent practice association model HMO. She then worked with CareFirst BlueCross BlueShield where she managed more than $600 million in claims expenditures. Her experience includes: establishing risk-sharing and bundled payment arrangements with specialty providers, disease management contractors and integrated delivery systems.

Jennifer has conducted extensive radiation oncology regulatory and policy analysis, working with the American College of Radiation Oncology (ACRO) managing their economic and regulatory policy efforts. Her expertise also includes precision medicine and oncology, and she has recently completed projects for the Center for Medical Technology Policy, including reviewing how evolving genomic testing may dramatically impact oncology care. Her recent publication on clinical integration of next generation sequencing explored the coverage and reimbursement challenges of precision medicine testing. Following her work as a Fellow at the Presidential Commission for the Study of Bioethical Issues, working on the Privacy and Progress in Whole Genome Sequencing Report, she lectured on the challenging questions raised by precision medicine and oncology.

Jennifer has an MBA from Wharton and a Masters of Bioethics degree from the University of Pennsylvania. She recently served as a Wharton panelist, offering insight on the impact of the rising costs of cancer care, and she was a recent lecturer at the Thomas Jefferson University’s Jefferson College of Population Health on the challenges raised by genomic advances. Jennifer is also a member of the Genetic Alliance Institutional Review Board.